Sort   by:  
 Page size 
ProteomicsCDK4/6 inhibition promotes anti-tumor immunity
Pharmacologicalinhibitors of cyclin dependent kinases 4 and 6 (CDK4/6) are an approvedtreatment forhormone receptor-positive breast cancer and are currently under evaluation across hundreds of clinical trials for other cancertypes. The clinical success of these inhibitorsis largely attributedto well...
ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse) 
2021-06-08 | PXD026539 | Pride
Cdk4 T-cell Phosphoproteomics Cdk6 
GenomicsPol2Chip
Pol2
EGAD00010000860 | EGA
GenomicsH3K27me3Chip
H3K27me3
EGAD00010000862 | EGA
Genomicsena-DATASET-CRUK-CI-11-11-2015-15:28:33:473-12 - samples
Data from the paper Context-specific Effects of TGFβ/SMAD3 in Cancer Are Modulated by the Epigenome. Tufegdzic et al, Cell Reports 2015
EGAD00001001668 | EGA
GenomicsExpression
Expression Arrays
EGAD00010000867 | EGA
GenomicsH3K27AcChip
H3K27Ac
EGAD00010000863 | EGA
GenomicsMBDSEQ
MBDSEQ
EGAD00010000865 | EGA
Genomicsena-DATASET-CRUK-CI-11-11-2015-14:57:45:115-9 - samples
Data from the paper Context-specific Effects of TGFβ/SMAD3 in Cancer Are Modulated by the Epigenome. Tufegdzic et al, Cell Reports 2015
EGAD00001001667 | EGA
GenomicsAza
Targeted bisulfite sequencing
EGAD00010000868 | EGA
GenomicsSmadChip
Smad3
EGAD00010000859 | EGA
Sort   by:  
 Page size